This 123.6 kb intragenic deletion appears to include a regulatory sequence that controls Dlx5 expression at least in the otocyst so this mutant provides a model of split-hand/foot malformation 1 (SHFM1) without craniofacial defects and a model with which to dissect the regulation of the genomic region that includes Dlx5 and Slc25a13.Read More +
|Allele Type||Gene Symbol||Gene Name|
|Spontaneous (Null/Knockout, Dominant negative)||Slc25a13||solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 13|
|Marker Symbol||Marker Name|
|Dlx5||distal-less homeobox 5|
The hyperspin mutation is a spontaneous 123.6 kb deletion that begins in intron 3 of Slc25a13 and ends in exon 17, an interval that includes an enhancer of Dlx5. This deletion includes the putative enhancer elements hs2313 and hs1642, and overlaps the regions corresponding to the predicted intervals of split-hand/foot malformation (SHFM) and split-hand/foot malformation with hearing loss (SHFM & HL) sub-regions of the SHFM1 locus, but not the split-hand/foot malformation with hearing loss and craniofacial abnormalities (SHFM & HL & CF) sub-region. Hyperspin homozygotes exhibit the phenotypes indicative of a vestibular defect, rapid circling, head shaking, and failure to orient in water, but null alleles in Slc25a13 have not been found to cause vestibular defects. At 4 to 5 weeks of age homozygotes were found to be deaf by ABR analysis. At 5 weeks of age the inner ears of homozygotes are small and malformed, the cochlea has too few turns and appears swollen, and the three semicircular canals are absent, reduced, or malformed. At embryonic day 15.5 the endolymphatic duct and sac and the superior and posterior semicircular canals are missing, the cochlear duct is wider and has fewer coils than normal, and most homozygotes also lack the lateral semicircular canal and utricle. Scanning electron microscopy of the basal and middle turns of the cochlea at 4 weeks of age revealed only occasional missing hair bundles, but the apical turn had an additional forth and sometimes fifth row of outer hair cells and abnormal hair bundle orientations. Only approximately 30% of female and 50% of male hyperspin homozygotes survive to wean age. Hyperspin homozygotes have reduced otocyst expression but not branchial arch expression of Dlx5, a gene more than 600 kb away on Chromosome 6, and null alleles of Dlx5 have been found to cause perinatal death, dysmorphic inner ears and other craniofacial abnormalities. While hyperspin heterozygotes have a normal phenotype fewer than 10% of Slc25a13hspn Dlx5+/Slc25a13+ Dlx5tm1(cre/ERT2)Zjh transchromosomal heterozygotes survive to wean age, a more severe phenotype than that of hyperspin homozygotes and further proof of the presence of a Dlx5 modifier within the hyperspin deletion. These double heterozygotes display circling and head bobbing, are deaf by ABR, and have malformed inner ears similar to that found in hyperspin homozygotes.
To identify the sequence within the hyperspin deletion that regulates Dlx5 otic expression, endonuclease-mediated deletions were generated of hs2313 in intron 14, hs1642 in intron 3, and intron 3 through 4. None of these caused the phenotype found in hyperspin homozygotes, even when Dlx5tm1(cre/ERT2)Zjh transchromosomal heterozygotes were generated.
The hyperspin deletion arose spontaneously in the CXJ1/SalkJ strain at The Jackson Laboratory and it was later determined that the mutation arose in SLJ/J-derived sequence. This mutation was moved onto the C57BL/6J background by repeated backcross-intercross breeding until generation N10 when sibling intercrossing of heterozygous females with homozygous males began. Embryos were cryopreserved from C57BL/6J females bred to homozygous males at generation N10F3.
|Allele Type||Spontaneous (Null/Knockout, Dominant negative)|
|Gene Symbol and Name||Slc25a13, solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 13|
|Strain of Origin||SJL/J|
|Molecular Note||The hyperspin mutation is a spontaneous 123.6 kb deletion of Chromosome 6: 5.86-6.66 Mb (GRCm38) that begins in intron 3 of Slc25a13 and ends in exon 17, an interval that includes an enhancer of Dlx5 and, in addition to creating a null allele of Slc25a13, diminishes otocyst expression of Dlx5.|
"MICE" means mouse strains, their progeny derived by inbreeding or crossbreeding, unmodified derivatives from mouse strains or their progeny supplied by The Jackson Laboratory ("JACKSON"). "PRODUCT(S)" means biological materials supplied by JACKSON, and their derivatives. "SERVICES" means projects conducted by JACKSON for other parties that may include but are not limited to the use of MICE or PRODUCTS. "RECIPIENT" means each recipient of MICE, PRODUCTS, or SERVICES provided by JACKSON including each institution, its employees and other researchers under its control. MICE or PRODUCTS shall not be: (i) used for any purpose other than internal research, (ii) sold or otherwise provided to any third party for any use, or (iii) provided to any agent or other third party to provide breeding or other services. Acceptance of MICE, PRODUCTS or SERVICES from JACKSON shall be deemed as agreement by RECIPIENT to these conditions, and departure from these conditions requires JACKSON’s prior written authorization.
MICE, PRODUCTS AND SERVICES ARE PROVIDED "AS IS". JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of, PRODUCTS or SERVICES, JACKSON will, at its option, provide credit or replacement for the PRODUCT received or the SERVICES provided; JACKSON makes no other representations and this shall be the exclusive remedy of the purchaser. Please note specific policy for live mice.
Consistent with the requirement for a written understanding regarding animal care and use, the JACKSON Animal Care and Use Committee will review the animal care and use protocol(s) associated with any SERVICES to be performed at JACKSON, and JACKSON shall have ultimate responsibility and authority for the care of animals while on site or in JACKSON custody.
In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS, or SERVICES, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS, or SERVICES from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.
MICE, PRODUCTS or SERVICES are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or SERVICES. In addition, special terms and conditions of sale of certain MICE, PRODUCTS, or SERVICES may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and SERVICES by JACKSON, and by its licensees and distributors.
Acceptance of delivery of MICE, PRODUCTS or SERVICES shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or SERVICES by JACKSON.